Literature DB >> 9573358

Rapid identification of Leishmania species from formalin-fixed biopsy samples by polymorphism-specific polymerase chain reaction.

T Mimori1, J Sasaki, M Nakata, E A Gomez, H Uezato, S Nonaka, Y Hashiguchi, M Furuya, H Saya.   

Abstract

The precise identification and classification of Leishmania species is important for public health surveillance since different species cause different clinical features of the disease. A highly specific polymerase chain reaction (PCR) panel was developed to enable the identification of the five major Leishmania species that cause New World cutaneous leishmaniases. The primers used for this panel were designed to distinguish the polymorphism in sequences of commonly amplified DNA bands of the parasites produced by arbitrarily primed PCR. These polymorphism-specific PCR diagnoses were performed with formalin-fixed biopsy specimens of the leishmanial lesions from four patients in Ecuador and one hamster skin lesion, and these lesions were determined to be caused by Leishmania (Viannia) panamensis, L. (Leishmania) mexicana, and L. (L.) amazonensis. The PCR panel may offer an important and practical approach to the standardized identification of Leishmania species in field examinations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573358     DOI: 10.1016/s0378-1119(97)00663-x

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  PCR-based diagnosis of acute and chronic cutaneous leishmaniasis caused by Leishmania (Viannia).

Authors:  Kristen A Weigle; Luz Angela Labrada; Caterin Lozano; Cecilia Santrich; Douglas C Barker
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

2.  Consecutive cutaneous and visceral leishmaniasis manifestations involving a novel Leishmania species in two HIV patients in Thailand.

Authors:  Sarunyou Chusri; Thanaporn Hortiwakul; Khachornsakdi Silpapojakul; Padet Siriyasatien
Journal:  Am J Trop Med Hyg       Date:  2012-07       Impact factor: 2.345

Review 3.  Species typing in dermal leishmaniasis.

Authors:  Gert Van der Auwera; Jean-Claude Dujardin
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

4.  Ixodid fauna and zoonotic agents in ticks from dogs: first report of Rickettsia rickettsii in Rhipicephalus sanguineus in the state of Mato Grosso do Sul, mid-western Brazil.

Authors:  Robson Ferreira Cavalcante de Almeida; Marcos Valério Garcia; Rodrigo Casquero Cunha; Jaqueline Matias; Elaine Araújo e Silva; Maria de Fatima Cepa Matos; Renato Andreotti
Journal:  Exp Appl Acarol       Date:  2012-12-11       Impact factor: 2.132

5.  New PCR assay using glucose-6-phosphate dehydrogenase for identification of Leishmania species.

Authors:  Tiago M Castilho; Jeffrey Jon Shaw; Lucile M Floeter-Winter
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

6.  Polymorphism-specific PCR enhances the diagnostic performance of American tegumentary leishmaniasis and allows the rapid identification of Leishmania species from Argentina.

Authors:  Jorge D Marco; Paola A Barroso; Tatsuyuki Mimori; Fabricio M Locatelli; Ayako Tomatani; María C Mora; S Pamela Cajal; Julio R Nasser; Luis A Parada; Taketoshi Taniguchi; Masataka Korenaga; Miguel A Basombrío; Yoshihisa Hashiguchi
Journal:  BMC Infect Dis       Date:  2012-08-15       Impact factor: 3.090

7.  Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon.

Authors:  Jorge Augusto de Oliveira Guerra; Suzane Ribeiro Prestes; Henrique Silveira; Leila Inês de Aguiar Raposo Câmara Coelho; Pricila Gama; Aristoteles Moura; Valdir Amato; Maria das Graças Vale Barbosa; Luiz Carlos de Lima Ferreira
Journal:  PLoS Negl Trop Dis       Date:  2011-03-08

8.  Cost-effectiveness analysis of Mucosal Leishmaniasis diagnosis with PCR-based vs parasitological tests in Colombia.

Authors:  Liliana Castillo-Rodríguez; Clemencia Ovalle-Bracho; Diana Díaz-Jiménez; Guillermo Sánchez-Vanegas; Sandra Muvdi-Arenas; Carlos Castañeda-Orjuela
Journal:  PLoS One       Date:  2019-11-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.